Pharmacology of valsartan, an angiotensin II receptor antagonist-Reference-Cited by-同舟云学术

Pharmacology of valsartan, an angiotensin II receptor antagonist

Published:1998-11 Issue:11 Volume:7 Page:1915-1925
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Chiolro Arnaud¹,Burnier Michel¹

Affiliation:

1. Division of Hypertension and Vascular Medicine, Department of Medicine, CHUV and Policlinique Médicale Universitaire, Lausanne, Switzerland. Tel: +41 21 345 22 22; Fax: +41 21 345 20 19; Email: Michel.Burnier@chuv.hospvd.ch

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.7.11.1915

Reference41 articles.

1. Angiotensin-Converting Enzyme Inhibitors

2. Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

3. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New stability indicating liquid chromatographic method for the estimation of Valsartan in pharmaceutical dosage forms;Research Journal of Pharmacy and Technology;2023-03-31

2. Strength-Dependent and Strength-Independent Dissolution Patterns of Poorly-Soluble Drugs. Case Example: Valsartan;Pharmaceutical Chemistry Journal;2021-03

3. Candesartan and valsartan Zn(ii) complexes as inducing agents of reductive stress: mitochondrial dysfunction and apoptosis;New Journal of Chemistry;2021

4. Synthesis of Valsartan as drug for the treatment of hypertension;Vietnam Journal of Chemistry;2019-06

5. Physiological parameters of the gastrointestinal fluid impact the dissolution behavior of the BCS class IIa drug valsartan;Pharmaceutical Development and Technology;2018-11-26